Avacta Group PLC - Wetherby, England-based life sciences company developing targeted oncology drugs and diagnostics - Issues 3.8 million new shares of 10 pence each to settle quarterly principal of £2.6 million and interest repayment of £760,000. After settlement of the quarterly repayment, the principal remaining under the convertible bond will be reduced by £2.6 million to £44.2 million.

Current stock price: 99.00 pence

12-month change: down 11%

Copyright 2023 Alliance News Ltd. All Rights Reserved.